© 2026 Columbia Data Analytics, LLC. All rights reserved. Terms, Conditions, and Privacy
Below is a selection of peer-reviewed outcomes research publications co-authored by CDA researchers and collaborators. Use the search field to filter by keyword or topic.
For questions about our publications or related research, please contact us.
Publication / Presentation Year | Therapeutic Area | Journal / Conference | Title |
|---|---|---|---|
2026 | Women's Health, Mental Health, Healthcare Policy | Socioeconomic status and postpartum depression risk after the Dobbs v Jackson Women’s Health Organization Decision, based on state trigger laws | |
2026 | Oncology | Prevalence, economic burden, and healthcare utilization among Medicare and commercially insured oropharyngeal cancer patients | |
2026 | Oncology | Cancer Med (In press) | Analysis of treatment patterns in patients with mucosal melanoma using real-world data in the SEER-Medicare–linked database |
2026 | Mental Health, Healthcare Policy | Am J Managed Care (In press) | The effect of Medicaid reimbursement policies on serious mental illness outcomes |
2026 | Women's Health, Mental Health, Healthcare Policy | Womens Health Issues (In press) | Evaluating the relationship between maternal healthcare policies and practices on postpartum depression (PPD) diagnosis incidence in the US |
2026 | Women's Health, OB/GYN | Contraception (In press) | Safety of medication abortion: Analysis of insurance claims, 2017-2024 |
2026 | Oncology, Rare Disease, Modeling / Methodology | AMCP Annual Meeting | Budget impact/cost-offset model comparing once-daily extended-release vs twice-daily immediate-release ruxolitinib in myelofibrosis: A US payer perspective |
2026 | Endocrinology, Diabetes | AMSUS Annual Meeting | Evaluating prevalence and incidence of type 1 diabetes in the US Department of War population |
2026 | Vaccine | RSVVW | Administration timing of respiratory syncytial virus (RSV) preventives for infants in the United States: A descriptive retrospective observational study of the 2024 – 2025 RSV season |
2025 | Endocrinology, Nephrology | External control arm with real-world data to assess the effect of semaglutide on chronic kidney disease risk among patients with type 2 diabetes | |
2025 | Healthcare Policy, Mental Health | The impact of copay accumulators and maximizers on treatment patterns, adherence, and costs among patients with major depressive and bipolar disorders treated with branded therapies | |
2025 | Healthcare Policy, Mental Health | Impact of Medicaid Institution for Mental Diseases exclusion on serious mental illness outcomes | |
2025 | Mental Health, Healthcare Policy | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness | |
2025 | Rare Disease, Dermatology, Immunology | Analysis of rare events in healthcare intervention using Department of Defense data: Intravenous immune globulin therapy for bullous pemphigoid | |
2025 | Mental Health, Women's Health, Healthcare Policy | The effect of Dobbs v. Jackson Women’s Health Organization on clinical diagnosis of postpartum depression | |
2025 | Oncology | ISPOR Europe | Overall treatment landscape of mucosal melanoma |
2025 | Mental Health, Healthcare Policy | ISPOR Europe | Socioeconomic disparities in access to treatment for major depressive disorder: The role of accumulator and maximizer insurance plans |
2025 | Mental Health | ISPOR Europe | Comparative prevalence of suicidal ideation and self-harm history: Rexulti vs other oral atypical antipsychotics |
2025 | Healthcare Policy | ISPOR Europe | Effect of the Inflation Reduction Act on drug innovation |
2025 | Women's Health, Infection | ISPOR Europe | Does the abortion pill harm women? Serious adverse events following mifepristone abortion in US commercial and Medicaid populations |
2025 | Healthcare Policy, Mental Health | ISPOR Europe | Socioeconomic disparities in postpartum depression following abortion restrictions: A difference-in-differences analysis of Medicaid data post-Dobbs |
2025 | Mental Health / Healthcare Policy | AMCP Nexus | The impact of copay accumulators and maximizers on treatment patterns and costs among patients with major depressive and bipolar disorders treated with branded mental health treatments |
2025 | Neurology | AMCP Nexus | Improved outcomes in patients with multiple sclerosis initiating cladribine tablets compared with those denied health insurance coverage in the United States |
2025 | Women's Health / Mental Health | AMCP Nexus | Socioeconomic vulnerabilities and postpartum depression: Assessing the aftermath of Dobbs v Jackson in trigger and non-trigger states |
2025 | Mental Health | Psych Congress | Real-world healthcare resource utilization and costs among individuals living with schizophrenia who transitioned to aripiprazole 2-month ready-to-use formulation |
2025 | Mental Health | Psych Congress | Real-world healthcare resource utilization and costs among US individuals living with bipolar-I disorder who transitioned to aripiprazole 2-month ready-to-use formulation |
2025 | Mental Health | Psych Congress | Real-world impact of transitioning from oral or once-monthly injectable aripiprazole to a 2-month ready-to-use aripiprazole formulation on adherence and healthcare utilization in US adults diagnosed with schizophrenia |
2025 | Mental Health | Academy of Managed Care Pharmacy (AMCP) Annual Meeting | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness |
2025 | Women's Health / Mental Health | Academy of Managed Care Pharmacy (AMCP) Annual Meeting | Real-world treatment patterns, healthcare resource utilization and costs for Medicaid patients with a postpartum depression diagnosis |
2025 | Mental Health | ISPOR Annual Meeting | Shades of blue: Investigating racial, socioeconomic, and family dynamics in depression among teen girls |
2025 | Women's Health / Mental Health | ISPOR Annual Meeting | Postpartum depression: Assessing the aftermath of Dobbs v. Jackson in trigger and non-trigger states |
2025 | Endocrinology / Nephrology | ISPOR Annual Meeting | External control arm with real world data to assess the effect of semaglutide on chronic kidney disease risk among patients with type 2 diabetes |
2025 | Hepatology | ISPOR Annual Meeting | Machine learning algorithms for identifying undiagnosed nonalcoholic steatohepatitis: A Veterans Affairs health system study |
2025 | Obesity / Cardiovascular | ISPOR Annual Meeting | Socioeconomic status and anti-obesity medications: Impact on cardiovascular risk in Medicare patients with obesity |
2025 | Mental Health | ISPOR Annual Meeting | Comparison of suicidal ideation or personal history of self harm among patients with use of Rexulti and all antipsychotics |
2025 | Mental Health | Psych Elevate Congress | Treatment patterns and healthcare resource utilization among patients receiving the long-acting injectable antipsychotic TV-46000 vs second-generation oral antipsychotics |
2025 | Mental Health | Psych Elevate Congress | Real-world clinical outcomes among patients receiving the long-acting injectable antipsychotic TV-46000 versus second-generation oral antipsychotics |
2025 | Public Health, Mental Health, Addiction | Prevalence and risk factors among patients with alcohol use disorder during COVID-19: National Survey on Drug Use and Health Analysis | |
2025 | Mental Health, Women's Health | American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting | Evaluating the relationship between Medicaid postpartum depression (PPD) screening and coverage policies on PPD diagnosis incidence in the United States |
2025 | Obesity, Endocrinology | Tirzepatide and semaglutide for the treatment of obstructive sleep apnea and obesity: A retrospective analysis | |
2024 | Oncology | Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide | |
2024 | Obesity, Endocrinology | The association between weight loss medications and cardiovascular complications | |
2024 | Obesity, Endocrinology | The impact of newly approved anti-obesity medications on osteoarthritis | |
2024 | Obesity, Endocrinology | Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study | |
2024 | Obesity, Endocrinology | Semaglutide and tirzepatide use and reduction of cardiovascular risks in adults with overweight and obesity | |
2024 | Mental Health, Neurology | Neighborhood socioeconomic status and postpartum depression among commercial health insurance enrollees: A retrospective cohort study | |
2024 | Hepatology, Methodology | Artificial intelligence in identifying patients with undiagnosed nonalcoholic steatohepatitis | |
2024 | Mental Health | Behind the sadness of teen girls: A retrospective survey analysis | |
2024 | Mental Health | Mental health disparities in young adults with arrest history: A survey-based, cross-sectional analysis | |
2024 | Healthcare Policy, Mental Health, Neurology | Psych Congress | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness |
2023 | Dataset Comparison | Use of open claims vs closed claims in health outcomes research | |
2023 | Virology | Short-term and long-term behavioral effects of vaccination mandates | |
2023 | Mental Health | Factors associated with the prevalence and treatment of depression in adolescent males in the US during the period of COVID-19 pandemic | |
2023 | Obesity, Endocrinology | Relationship between body mass index and diagnosis of overweight or obesity in Veterans Administration population | |
2019 | Mental Health / Neurology | Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis | |
2024 | Obesity / Endocrinology / Mental Health / Neurology | Comparative effect of Ozempic, Wegovy and Mounjaro on the incidence of alcohol and substance use disorder in patients with obesity | |
2024 | Mental Health / Neurology | Socioeconomic status and postpartum depression among commercial health insurance enrollees | |
2024 | Mental Health / Neurology | AMCP Annual Meeting | Open access for mental health medication: Impact on state Medicaid budgets |
2023 | Mental Health / Neurology | ISPOR EU | Mental health disparities for young adults with arrest history: A survey-based, cross-sectional analysis |
2024 | Obesity / Endocrinology | A retrospective analysis of the impact of approved anti-obesity medications on the risk of cardiovascular disease in patients with obesity | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of cardiovascular disease, healthcare resource use and costs among patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of osteoarthritis, healthcare resource use and costs among patients with obesity: A retrospective cohort study BEST RESEARCH POSTER AWARD | |
2024 | Obesity / Endocrinology | Anti-obesity medications and related osteoarthritis risk among patients with obesity | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the risk of obstructive sleep apnea in patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of obstructive sleep apnea, healthcare resource utilization and costs among patients with obesity: A retrospective cohort study FINALIST AWARD | |
2024 | Obesity / Endocrinology | Measuring the cardiovascular benefits of anti-obesity medications | |
2024 | Obesity / Endocrinology | Head-to-head comparison of healthcare costs and utilization among patients with semaglutide vs tirzepatide use | |
2024 | Obesity / Endocrinology | Likelihood of osteoarthritis among users of anti-obesity medications | |
2024 | Obesity / Endocrinology | Likelihood of obstructive sleep apnea among patients with obesity and anti-obesity medication use | |
2024 | Obesity / Endocrinology | Effect of anti-obesity medications on cardiovascular events in the Veterans Affairs patient population | |
2024 | Obesity / Endocrinology | Effect of weight loss medications on cardiovascular risk among active US military personnel BRONZE RIBBON AWARD | |
2024 | Obesity / Endocrinology | Cardiovascular benefits of weight loss medications: An analysis of Mounjaro and Wegovy in the US Medicare population | |
2024 | Virology | American Public Health Association (APHA) Annual Meeting & Expo | The association between socioeconomic status and the likelihood and severity of RSV-attributable lower respiratory infections in infants |
2024 | Virology | Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting | The association between socioeconomic status and maternal risk factors on the likelihood and severity of RSV-attributable lower respiratory infections from MarketScan data |
2024 | Oncology | The cardiovascular effect of abiraterone and enzalutamide among Veterans Affairs’ metastatic castration-resistant prostate cancer patients PODIUM PRESENTATION | |
2024 | Obesity / Endocrinology | The effect of newly approved obesity medications on cardiovascular complications | |
2024 | Obesity / Endocrinology / Mental Health | The effect of approved anti-obesity medications in patients with alcohol and substance use disorder | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on osteoarthritis risk in patients with obesity: A retrospective cohort study | |
2024 | Hepatology / Methodology | Predictive risk score for nonalcoholic steatohepatitis among patients in the Department of Defense population | |
2024 | Mental Health / Neurology | Psych Congress | The effect of Medicaid reimbursement policies on serious mental illness outcomes |
2024 | Mental Health / Neurology | Psych Congress | The effect of the Medicaid institutions for mental disease exception on serious mental illness outcomes |
2024 | Obesity / Endocrinology | Impact of Ozempic vs Wegovy on osteoarthritis risk in obese patients: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The effect of approved obesity medications on obesity’s cardiovascular related comorbidities | |
2023 | Oncology | AMCP Nexus | Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide in Veteran Affairs |
2023 | Virology / Vaccine | ISPOR EU | The short-run and long-run behavioral effects of vaccination enforcement in Turkey |
2023 | Immunology | ISPOR EU | Direct medical costs associated with rheumatoid arthritis in Turkey: Analysis from a national claims database |
2023 | Oncology | ISPOR Annual | Effect of surgical choices on the cost of breast cancer care |
2023 | Obesity / Endocrinology | ISPOR Annual | Relationship between body mass index and diagnosis of overweight or obesity in Veteran’s Administration population |
2023 | Hepatology / Methodology | ISPOR Annual | Applying machine learning techniques to identify undiagnosed patients with nonalcoholic steatohepatitis |
2023 | Virology / Vaccine | ISPOR Annual | The short run and long run behavioral effects of COVID-19 vaccination enforcement |
2023 | Immunology | ISPOR Annual | Analysis of rare events in outcomes research using Department of Defense data: Intravenous immune globulin therapy for bullous pemphigoid |
2023 | Database Comparison | ISPOR Annual | Use of open claims vs closed claims on health outcomes research |
2023 | Methodology | ISPOR Annual | Review of machine learning based disease diagnosis modeling |
2023 | Cardiovascular | Geographic variation in clinical outcomes and anticoagulation among Medicare beneficiaries with non-valvular atrial fibrillation | |
2023 | Cardiovascular | Temporal trends in anticoagulation use and clinical outcomes among Medicare beneficiaries with non-valvular atrial fibrillation | |
2023 | Cardiovascular | Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States | |
2023 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin in patients with venous thromboembolism with risk factors for bleeding or for recurrences | |
2023 | Cardiovascular | Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study | |
2023 | Cardiovascular | Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and multimorbidity | |
2022 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding | |
2022 | Cardiovascular | Risk levels and adverse clinical outcomes among patients with nonvalvular atrial fibrillation receiving oral anticoagulants | |
2023 | Cardiovascular | Oral anticoagulant underutilization among elderly patients with atrial fibrillation: Insights from the United States Medicare database | |
2022 | Cardiovascular | Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: A retrospective analysis of administrative claims databases | |
2022 | Cardiovascular | Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database | |
2022 | Cardiovascular | Non-persistence to oral anticoagulation treatment in non-valvular atrial fibrillation patients in the United States | |
2021 | Virology / Vaccine / Public Health | Population density index and its use for distribution of Covid-19: A case study using Turkish data | |
2021 | Immunology | Prevalence of mastocytosis and Hymenoptera venom allergy in the United States | |
2021 | Cardiovascular / Oncology | Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients with active cancer | |
2021 | Cardiovascular | Effectiveness and safety of apixaban versus warfarin among older patients with venous thromboembolism with different demographics and socioeconomic status | |
2021 | Cardiovascular | Non-persistence to oral anticoagulation treatment in non-valvular atrial fibrillation patients in the United States | |
2021 | Cardiovascular | Oral anticoagulants for nonvalvular atrial fibrillation in patients with high risk of gastrointestinal bleeding | |
2021 | Cardiovascular | Use of non-vitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and multimorbidity | |
2021 | Cardiovascular | Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients | |
2021 | Cardiovascular | Clinical and economic outcomes among non-valvular atrial fibrillation patients with coronary artery disease and/or peripheral artery disease | |
2021 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin in venous thromboembolism patients with obesity and morbid obesity | |
2021 | Cardiovascular | Oral anticoagulants for non-valvular atrial fibrillation in frail elderly patients: Insights from the ARISTOPHANES study | |
2021 | Cardiovascular | Safety and effectiveness of apixaban compared with warfarin among clinically relevant subgroups of venous thromboembolism patients in the United States Medicare population | |
2021 | Cardiovascular | Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy | |
2020 | Virology / Infectious Disease | Real-world adherence and persistence for newly-prescribed HIV treatment: Single versus multiple tablet regimen comparison among US Medicaid beneficiaries | |
2020 | Oncology | Economic outcomes in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate plus prednisone | |
2020 | Oncology / Rare Diseases | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data | |
2020 | Cardiovascular / Pulmonary | Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: A retrospective database analysis | |
2020 | Cardiovascular | Effectiveness and safety of oral anticoagulants among NVAF patients with obesity: Insights from the ARISTOPHANES Study | |
2020 | Cardiovascular | Effectiveness and safety of oral anticoagulants in patients with nonvalvular atrial fibrillation and diabetes mellitus | |
2020 | Hematology / Rare Diseases / Hereditary Diseases | Medical resource use and costs of treating sickle cell-related vaso-occlusive crisis episodes: A retrospective claims study | |
2020 | Oncology / Rare Diseases | Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis | |
2020 | Infectious Disease / Virology | Predictors and outcomes of hospitalization for influenza: Real-world evidence from the United States Medicare population | |
2020 | Respiratory / Virology | A real-world analysis of patient characteristics and predictors of hospitalization among US Medicare beneficiaries with respiratory syncytial virus infection | |
2020 | Mental Health | An evaluation of the clinical and economic burden among older adult Medicare-covered beneficiaries with treatment-resistant depression | |
2019 | Hematology / Rare Disease / Hereditary Disease | Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study | |
2019 | Cardiovascular | Healthcare resource utilization and expenditures among newly diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants | |
2019 | Cardiovascular | Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population | |
2019 | Cardiovascular | Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients | |
2019 | Cardiovascular | Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population | |
2019 | Cardiovascular | Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure | |
2019 | Cardiovascular | Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: A retrospective cohort study | |
2019 | Cardiovascular | Risk of venous thromboembolism after new onset heart failure | |
2019 | Cardiovascular | The value of sPESI for risk stratification in patients with pulmonary embolism | |
2019 | Oncology | ISPOR Annual | Real-world evidence of the economic burden and risk factors for hospitalization among patients with myeloma in the US Veterans Health Administration population |
2019 | Cardiovascular | ISPOR Annual | Assessing the risk factors of heart failure among patients in the US Department of Defense population |
2019 | Hepatology | ISPOR Annual | Assessing the economic burden and hospitalization among patients with non-alcoholic steatohepatitis in the US Veterans Health Administration population |
2019 | Respiratory | ISPOR Annual | Examining the risk factors of chronic obstructive pulmonary disease among patients in the Department of Defense population |
2019 | Immunology | ISPOR Annual | Assessing the economic burden and predictors of hospitalization among US veteran patients with rheumatoid arthritis: A retrospective case-control study |
2019 | Oncology | Annual Meeting of the American Urological Association (AUA) Education and Research Inc | Survival rates and economic outcomes in chemotherapy-naïve metastatic castrate resistant prostate cancer patients treated with abiraterone acetate or enzalutamide |
2019 | Oncology | Annual Meeting of the American Urological Association (AUA) Education and Research Inc. | Impact of prostate specific antigen doubling time on metastasis and increased costs associated with progression to metastatic castrate-resistant prostate cancer |
2019 | Respiratory | AMCP Annual | Assessing economic burden and hospitalization among asthma patients in the US Veterans Health Administration population |
2019 | Oncology / Rare Disease | European School of Haematology: How to Diagnose and Treat CML/MPN | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data |
2019 | Oncology | American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium | Impact of prostate specific antigen doubling time on time to metastasis and overall survival in nonmetastatic castration-resistant prostate cancer patients |
2019 | Oncology | American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium | Overall survival by race in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide |
2019 | Public Health | Network among HTA ecosystem | |
2019 | Public Health / Policy | Does the unification of health financing affect the distribution pattern of out‐of‐pocket health expenses in Turkey? | |
2019 | Obesity / Endocrinology | Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1 RAs in type II diabetes patients | |
2019 | Cardiovascular Diseases | Predictors of hospital length of stay among patients with low-risk pulmonary embolism | |
2019 | Respiratory | The burden of hypoxic respiratory failure in preterm and term/near-term infants in the United States 2011-2015 | |
2019 | Mental Health | Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis | |
2019 | Oncology / surgery | Impact of surgical approach on short-term oncological outcomes and recovery following low anterior resection for rectal cancer | |
2019 | Oncology / surgery | The effect of the breast cancer provider discussion law on breast reconstruction rates in New York state | |
2019 | Oncology / Hematology / Rare disease | Hematocrit levels and thrombotic events in patients with polycythemia vera: An analysis of Veterans Health Administration data | |
2019 | Respiratory | Reduction in hospital readmission rates among Medicare beneficiaries with chronic obstructive pulmonary disease: A real-world outcomes study of nebulized bronchodilators | |
2019 | Hematology / Hereditary Diseases / Rare Diseases | Sickle cell disease complications: Prevalence and resource utilization | |
2019 | Hematology / Hereditary Diseases / Rare Diseases | Evaluation of vaso-occlusive crises in United States sickle cell disease patients: A retrospective claims-based study | |
2018 | Rare Diseases | Health care costs and comorbidities for patients with inclusion body myositis | |
2018 | Surgery | Smoking and postoperative complications in plastic and general surgical procedures: A propensity-score matched analysis of 294,903 patients from the NSQIP database from 2005-2014 | |
2018 | Oncology | Cytoreductive treatment patterns among US veterans with polycythemia vera | |
2018 | Oncology | Costs of relapsed diffuse large B-cell lymphoma among Medicare patients | |
2018 | Oncology | Taxane chemotherapy versus anti-androgen agents as first-line therapy for metastatic castration-resistant prostate cancer | |
2018 | Immunology / Dermatology | Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population | |
2018 | Surgery | The effect of hospital familiarity with complex procedures on overall healthcare burden | |
2018 | Immunology / Dermatology | Evaluating the impact of treatment persistence on the economic burden of moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population | |
2018 | Neurology | An analysis of episodes of care among newly diagnosed Alzheimers patients: US Medicare population | |
2018 | Neurology | Economic burden, mortality and institutionalization in patients newly diagnosed with Alzheimer’s disease | |
2018 | Infectious Disease | Real-world persistence for newly prescribed HIV-1 treatment: Single versus multiple tablet regimen comparison | |
2018 | Neurology | Adherence with extended-release oxcarbazepine (Oxtellar XR®) vs immediate-release oxcarbazepine: Analysis of pooled data from four national pharmacy claims databases | |
2018 | Gastrointestinal | Propensity score-matched analysis of clinical and financial outcomes after robotic and laparoscopic colorectal resection. | |
2018 | Cardiovascular Diseases | Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients: The ARISTOPHANES Study | |
2018 | Cardiovascular Diseases | Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and concomitant coronary/peripheral artery disease | |
2018 | Cardiovascular Diseases | J Manag Care Specialty Pharm | Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in non-valvular atrial fibrillation patients in the United States Department of Defense population |
2018 | Cardiovascular Diseases | A real-world observational study of hospitalization and health care costs among non-valvular atrial fibrillation patients prescribed oral anticoagulants in the United States Medicare population | |
2018 | Cardiovascular Diseases | East meets West: The influence of racial, ethnic and cultural risk factors on cardiac surgical risk model performance | |
2018 | Cardiovascular Diseases | Effect of renal function on dosing of non-vitamin K-antagonist direct oral anticoagulants among patients with non-valvular atrial fibrillation | |
2018 | Immunology / Rheumatology | Burden of rheumatoid arthritis in the US elderly population: Comorbidities, healthcare resource utilization, and costs | |
2018 | Women's Health | Long-term outcomes after elective sterilization procedures—A comparative retrospective cohort study of Medicaid patients | |
2018 | Immunology / Rheumatology | Evaluating the effect of treatment persistence on the economic burden of moderate to severe psoriasis and/or psoriatic arthritis patients in the U.S. Department of Defense population | |
2018 | Policy / Public Health | The relationship between medical innovation and health expenditure before and after health reform | |
2018 | Oncology / Surgery | Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer | |
2018 | Women's Health | Effectiveness of a private, orthopedic practice-based osteoporosis management program to reduce the risk of subsequent fractures | |
2018 | Policy / Public Health | Understanding the relationship between effectiveness and outcome indicators to improve quality in healthcare | |
2018 | Cardiovascular | Outcomes and prognostic factors for postsurgical pulmonary vein stenosis in the current era | |
2018 | Gastrointestinal | Alvimopan, regardless of ileus risk, significantly impacts ileus, length of stay, and readmission after intestinal surgery | |
2018 | Oncology | American Society of Hematology (ASH) Annual Meeting | Burden of CRAB events by relapse in patients with newly diagnosed multiple myeloma not eligible for stem cell transplant |
2018 | Oncology | American Society of Hematology (ASH) Annual Meeting | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data |
2018 | Oncology | ISPOR Europe | Healthcare utilization and economic burden on patients with bladder cancer in the US Department of Defense population |
2018 | Oncology | ISPOR Europe | Assessing the economic burden and 30- day readmission rates among patients with bladder cancer in the US Veterans Health Administration population |
2018 | Mental Health | US Psych Congress | Outcomes related to transition to once-every-three-monthly paliperidone palmitate among veterans with schizophrenia |
2018 | Mental Health | US Psych Congress | Economic burden of illness among US veterans with treatment-resistant depression |
2018 | Oncology | Academy of Managed Care Pharmacy (AMCP) Nexus | Economic burden of chemotherapy naïve metastatic castrate resistant prostate cancer patients treated with abiraterone acetate or enzalutamide in the United States |
2018 | Oncology | Academy of Managed Care Pharmacy (AMCP) Nexus | Increased costs associated with progression to metastatic castrate-resistant prostate cancer |
2017 | Public Health | Socio-economic status and self-rated health: Are they good predictors of income? An analysis of survey panel data from Turkey | |
2017 | Public Health | Spatial distribution of total number of medical devices in Turkey: A classification analysis | |
2017 | Mental Health | Epidemiology and economic burden of serotonin syndrome with concomitant use of serotonergic agents: A retrospective study utilizing two large US claims databases | |
2017 | Endocrinology | The use of decomposition methods in real- world treatment benefits evaluation for patients with type 2 diabetes initiating different injectable therapies: Findings from the INITIATOR study | |
2017 | Cardiology | Benefit of early discharge among patients with low-risk pulmonary embolism | |
2017 | Women's Health | Examining the effect of medication adherence on risk of subsequent fracture among women with a fragility fracture in the US Medicare population | |
2017 | Cardiology | Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States Medicare population | |
2017 | Neurology | A real-world analysis of treatment patterns for cholinesterase inhibitors and memantine among newly-diagnosed Alzheimer’s disease patients | |
2017 | Cardiology | Overall effectiveness of rivaroxaban in patients with pulmonary embolism | |
2017 | Women's Health | Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population | |
2017 | Public Health | Failure of efforts to contain costs of care after colorectal procedures: Nationwide trends in length of stay, costs and post-acute care utilization | |
2017 | Cardiology | External validation of a claims-based and clinical approach for predicting post- pulmonary embolism outcomes among United States veterans | |
2017 | Mental Health | Healthcare resource utilization and costs of California- Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment | |
2016 | Policy | Creating national weights for a patient-level longitudinal database | |
2016 | Infectious Disease | Burden of Clostridium difficile-associated disease among patients residing in nursing homes: A population-based cohort study | |
2016 | Infectious Disease | Mortality and costs in Clostridium difficile infection disease among the elderly in the US | |
2016 | Endocrinology | Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United States | |
2016 | Infectious Disease | Development and validation of a risk score for clostridium difficile infection in Medicare beneficiaries: A population-based cohort study | |
2016 | Cardiology | Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view | |
2016 | Cardiology | Patterns of international normalized ratio values among new warfarin patients with non- valvular atrial fibrillation | |
2016 | Cardiology | Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: A retrospective cohort study | |
2016 | Women's Health | The economic impact of symptomatic menopause among low-socioeconomic women in the United States | |
We have rich authorship and real-world evidence expertise with thousands of publications and presentations on a variety of life science topics in top-rated, peer-reviewed journals and industry proceedings.
We maintain relationships with universities and medical institutions to create a team of Key Opinion Leaders (KOLs) and faculty to consult and advise on publications.
The CDA team has an impressive peer-reviewed publication record, with international expertise in a wide variety of therapeutic areas. We have published more than 500 articles in high-quality journals such as JAMA, Medical Care, Health Policy, Curr Med Res Opin, J Med Econ, Value Health and many more. Our team members frequently review peer-reviewed journal articles and supply publication support.
CDA houses the Journal of Health Economics and Outcomes Research, an online journal with an external academic editorial board from top-level universities, with published papers from numerous well-known professors, scientists, universities, companies, and institutions and is currently indexed in PubMed, PubMed Central (PMC), DOAJ, and Google Scholar.
JHEOR operates independently of CDA’s client-based publication services. To learn more about JHEOR and read published articles, follow the link below.
145 Hudson Street, Suite 205
New York, NY 10013
332.264.0244
300 N. 5th Avenue, Suite 250
Ann Arbor, MI 48104
© 2026 Columbia Data Analytics, LLC. All rights reserved. Terms, Conditions, and Privacy